Register Login

PHARVARIS N.V. (PHVS)

Lesage Anne 🟡 adjusted position in 14.7K shares (3 derivative) of Pharvaris N.V. (PHVS) at $30.05 Transaction Date: Apr 22, 2026 | Filing ID: 176222

Full text
Register to leave comments
  • News bot April 24, 2026, 4:18 p.m.

    🔍 Lesage Anne (Executive)

    Company: Pharvaris N.V. (PHVS)

    Report Date: 2026-04-22

    Transaction Summary:

    • Total transactions: 11
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 7,600
    • Total shares sold: 22,300

    Detailed Transactions and Holdings:

    • Acquired 500 shares of Common Stock at $2.59 per share (Direct)
      Date: 2026-04-22 | Code: M | equity_swap_involved: false | shares_owned_after: 56,950.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 500 shares of Common Stock at $30.0 per share (Direct)
      Date: 2026-04-22 | Code: S | equity_swap_involved: false | shares_owned_after: 56,450.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 7,000 shares of Common Stock at $8.05 per share (Direct)
      Date: 2026-04-22 | Code: M | equity_swap_involved: false | shares_owned_after: 63,450.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 7,000 shares of Common Stock at $30.0517 per share (Direct)
      Date: 2026-04-22 | Code: S | equity_swap_involved: false | shares_owned_after: 56,450.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 7,000 shares of Common Stock at $30.0511 per share (Direct)
      Date: 2026-04-22 | Code: S | equity_swap_involved: false | shares_owned_after: 156,969.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 100 shares of Common Stock at $30.03 per share (Direct)
      Date: 2026-04-23 | Code: S | equity_swap_involved: false | shares_owned_after: 156,869.00 | transaction_form_type: 4
    • Acquired 100 shares of Common Stock at $2.59 per share (Direct)
      Date: 2026-04-23 | Code: M | equity_swap_involved: false | shares_owned_after: 56,550.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 100 shares of Common Stock at $30.03 per share (Direct)
      Date: 2026-04-23 | Code: S | equity_swap_involved: false | shares_owned_after: 56,450.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 500 shares of Stock Option (Right to Buy) at $2.59 per share (Derivative)
      Date: 2026-04-22 | Code: M | Expires: 2030-01-01 | equity_swap_involved: false | shares_owned_after: 15,972.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 7,000 shares of Stock Option (Right to Buy) at $8.05 per share (Derivative)
      Date: 2026-04-22 | Code: M | Expires: 2031-02-05 | equity_swap_involved: false | shares_owned_after: 113,000.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 100 shares of Stock Option (Right to Buy) at $2.59 per share (Derivative)
      Date: 2026-04-23 | Code: M | Expires: 2030-01-01 | equity_swap_involved: false | shares_owned_after: 15,872.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: This is a scheduled exercise and sale from 10b5-1 trading plan.
    • F2: These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13.
    • F3: These shares were sold in multiple transactions at prices ranging from $30.03 to $31.03.
    • F4: 25% of the option vested on January 1, 2020 with the remaining shares vesting in 1/48 monthly installments thereafter.
    • F5: 25% of the option vested on February 5, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.

Search

News categories